Your browser doesn't support javascript.
loading
Ribosomal Proteins Regulate MHC Class I Peptide Generation for Immunosurveillance.
Wei, Jiajie; Kishton, Rigel J; Angel, Matthew; Conn, Crystal S; Dalla-Venezia, Nicole; Marcel, Virginie; Vincent, Anne; Catez, Frédéric; Ferré, Sabrina; Ayadi, Lilia; Marchand, Virginie; Dersh, Devin; Gibbs, James S; Ivanov, Ivaylo P; Fridlyand, Nathan; Couté, Yohann; Diaz, Jean-Jacques; Qian, Shu-Bing; Staudt, Louis M; Restifo, Nicholas P; Yewdell, Jonathan W.
Afiliação
  • Wei J; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA. Electronic address: weijiajie@gmail.com.
  • Kishton RJ; National Cancer Institute, NIH, Bethesda, MD 20892, USA.
  • Angel M; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.
  • Conn CS; Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA.
  • Dalla-Venezia N; University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Center Léon Bérard, Center de Recherche en Cancérologie de Lyon, Lyon, 69373 Cedex 08, France.
  • Marcel V; University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Center Léon Bérard, Center de Recherche en Cancérologie de Lyon, Lyon, 69373 Cedex 08, France.
  • Vincent A; University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Center Léon Bérard, Center de Recherche en Cancérologie de Lyon, Lyon, 69373 Cedex 08, France.
  • Catez F; University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Center Léon Bérard, Center de Recherche en Cancérologie de Lyon, Lyon, 69373 Cedex 08, France.
  • Ferré S; University of Grenoble Alpes, CEA, INSERM, BIG-BGE, 38000 Grenoble, France.
  • Ayadi L; Next-Generation Sequencing Core Facility, UMS2008 IBSLor CNRS-INSERM-University of Lorraine, 54505 Vandoeuvre-les-Nancy, France; Laboratory IMoPA, UMR7365 CNRS-University of Lorraine, 54505 Vandoeuvre-les-Nancy, France.
  • Marchand V; Next-Generation Sequencing Core Facility, UMS2008 IBSLor CNRS-INSERM-University of Lorraine, 54505 Vandoeuvre-les-Nancy, France; Laboratory IMoPA, UMR7365 CNRS-University of Lorraine, 54505 Vandoeuvre-les-Nancy, France.
  • Dersh D; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.
  • Gibbs JS; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.
  • Ivanov IP; Laboratory of Gene Regulation and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD 20892, USA.
  • Fridlyand N; Laboratory of Translational Biology, School of Biosciences and Biotechnology, University of Camerino, Camerino MC 62032, Italy.
  • Couté Y; University of Grenoble Alpes, CEA, INSERM, BIG-BGE, 38000 Grenoble, France.
  • Diaz JJ; University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Center Léon Bérard, Center de Recherche en Cancérologie de Lyon, Lyon, 69373 Cedex 08, France.
  • Qian SB; Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA.
  • Staudt LM; Lymphoid Malignancies Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
  • Restifo NP; National Cancer Institute, NIH, Bethesda, MD 20892, USA; Center for Cell-Based Therapy, Center for Cancer Research, NIH, Bethesda, MD 20892, USA.
  • Yewdell JW; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA. Electronic address: jyewdell@niaid.nih.gov.
Mol Cell ; 73(6): 1162-1173.e5, 2019 03 21.
Article em En | MEDLINE | ID: mdl-30712990
ABSTRACT
The MHC class I antigen presentation system enables T cell immunosurveillance of cancers and viruses. A substantial fraction of the immunopeptidome derives from rapidly degraded nascent polypeptides (DRiPs). By knocking down each of the 80 ribosomal proteins, we identified proteins that modulate peptide generation without altering source protein expression. We show that 60S ribosomal proteins L6 (RPL6) and RPL28, which are adjacent on the ribosome, play opposite roles in generating an influenza A virus-encoded peptide. Depleting RPL6 decreases ubiquitin-dependent peptide presentation, whereas depleting RPL28 increases ubiquitin-dependent and -independent peptide presentation. 40S ribosomal protein S28 (RPS28) knockdown increases total peptide supply in uninfected cells by increasing DRiP synthesis from non-canonical translation of "untranslated" regions and non-AUG start codons and sensitizes tumor cells for T cell targeting. Our findings raise the possibility of modulating immunosurveillance by pharmaceutical targeting ribosomes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Ribossômicas / Linfócitos T / Antígenos de Histocompatibilidade Classe I / Apresentação de Antígeno / Subunidades Ribossômicas Maiores de Eucariotos / Subunidades Ribossômicas Menores de Eucariotos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Ribossômicas / Linfócitos T / Antígenos de Histocompatibilidade Classe I / Apresentação de Antígeno / Subunidades Ribossômicas Maiores de Eucariotos / Subunidades Ribossômicas Menores de Eucariotos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article